[Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential].
Four glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) have been characterized: GDNF, neurturin (NRTN), artemin (ARTN) and persephin (PSPN). These proteins support and restore multiple neuronal populations such as dopaminergic, sensory, motor, hippocampal, basal forebrain, enteric, sympathetic and parasympathetic neurons. Therefore, GFLs attracted significant attention as a potential cure for the diseases caused by neuronal injury and degeneration. Results of multiple experiments indicate that GFLs can alleviate behavioral symptoms and restore affected neurons in animal models of several neurological disorders including, among others, Parkinson's disease (PD). During the last decade, GDNF protein and NRTN gene therapy have been tested in several clinical trials in patients with PD. Although the results of phase I clinical trials were positive, phase II clinical trials failed to reach primary end-points. Poor pharmacokinetic properties of GFLs (inability to penetrate tissues barriers, high affinity for extracellular matrix, etc.) could contribute to the absence of clear clinical benefits of these proteins for the patients. The purpose of this paper was to review therapeutic potential of GFLs and discuss possibilities to overcome difficulties associated with pharmacokinetic properties and delivery of GFLs to target neurons.
Laboratory of Molecular Neuroscience, Institute of Biotechnology, Viikki Biocenter, Viikinkaari 5D, University of Helsinki 00014, Helsinki, Finland.
Y A
YA
Sidorova
Laboratory of Molecular Neuroscience, Institute of Biotechnology, Viikki Biocenter, Viikinkaari 5D, University of Helsinki 00014, Helsinki, Finland.|mart.saarma@helsinki.fi.
M
M
Saarma
GDNF family ligands (GFLs); GDNF family receptor α (GFRa); Parkinson's disease; RET receptor tyrosine kinase; artemin (ARTN); glial cell line-derived neurotrophic factor (GDNF); neuropathic pain; neurturin (NRTN); persephin (PSPN); small molecular weight GFL mimetics